European Crohn´s and Colitis Organisation - ECCO - ECCO News
ECCO 2019: Vedolizumab vs adalimumab in patients with active ulcerative colitis
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Topical Reviews
ECCO - European Crohn's and Colitis Organisation | eMedEvents
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Topical Reviews
Defining the Future of IBD Care: The Pivotal Role of Personalized Treatment” – ECCO 2019 - European Medical Journal
European Crohn´s and Colitis Organisation - ECCO - ECCO e-Guide
European Crohn´s and Colitis Organisation - ECCO - Volume 17, Issue 2 (Copy)
The IBD Management Puzzle: Do We Have All the Pieces? - European Medical Journal
European Crohn´s and Colitis Organisation - ECCO - Volume 15, Issue 3
PDF) ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
Guidelines | IBD-EII
Management of IBD during the COVID-19 outbreak: resetting clinical priorities | Nature Reviews Gastroenterology & Hepatology
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses - eClinicalMedicine
European Crohn´s and Colitis Organisation - ECCO - ECCO News
ECCO 2019 Archives - Medical Conferences
Elderly-onset IBD patients are less aggressively treated than younger patients
Variations to the current ECCO/ESPGHAN guidance as proposed by the RAND... | Download Scientific Diagram
Inflammatory Bowel Disease | UEG - United European Gastroenterology
Latest IBDoc® Publications from ECCO 2019 | IBDoc
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut
Diets for Management of IBD: Join us in Copenhagen March 2nd -4th
PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
BÜHLMANN IBDoc® Publications - Calprotectin Home Testing
EPOS™
ECCO guidelines & sites - GETAID
